Wednesday, April 24, 2024

Vanda Pharmaceuticals shares jump 30% after FDA approval of Fanapt for bipolar I disorder

Must read



The biopharmaceutical company said Tuesday the latest marketing approval increases the commercial opportunity of the treatment.



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article